Sintx Stock Quote Today

<div class='circular--portrait' style='background:#8B008B;color: #ffffff;font-size:3em;padding-top: 38px;;'>AMD</div>
Sintx is selling for under 0.02 as of the 28th of May 2020; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.02. Equity ratings for Sintx are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 28th of February 2020 and ending today, the 28th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

Sintx Profile

Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Amedica Corp is traded on BATS Exchange in USA. more on Sintx
Legal NameSintx
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Sintx available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Not RatedOver Valued
Sintx [AMDDW] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 664.86 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sintx's market, we take the total number of it shares issued and multiply it by the Sintx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Sintx has 3.02 M outstanding shares. The company has accumulated about 539 K in cash with (4.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sintx Probability Of Bankruptcy

Sintx Stock Against Markets

View Currently Related Equities

Please continue to Trending Equities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page